OpenAlex topic

Hepatitis B Virus Studies

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 4,931 works 287 author topics

Works

4,931 works

Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up 2017
YÖKSİS SJR Q2 JCR Q3 OpenAlex top 1% OpenAlex 100.0%
No abstract yet.
- AYSUN ÇALIŞKAN KARTAL
- RAMAZAN İDİLMAN
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial 2005
OpenAlex top 1% OpenAlex 100.0%
No abstract yet.
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2022
OpenAlex top 1% OpenAlex 100.0%
BACKGROUND: Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country Validation of Viral Hepatitis Elimination (WHO Interim Guidance). We es…
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 2022
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%
BACKGROUND: Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country Validation of Viral Hepatitis Elimination (WHO Interim Guidance). We es…
- VAHİT YİĞİT
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy 2016
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%
No abstract yet.
- RAMAZAN İDİLMAN
Page B Risk Score for Hepatocellular Carcinoma in Caucasians with Chronic Hepatitis B Under 5 Year Entecavir or Tenofovir Therapy 2015
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%
No abstract yet.
- RAMAZAN İDİLMAN
PAGE B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5 year antiviral therapy 2016
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%
No abstract yet.
- RAMAZAN İDİLMAN
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm 2014
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong…
- İSMAİL BALIK
- RAMAZAN İDİLMAN
Historical epidemiology of hepatitis C virus (HCV) in selected countries 2014
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
Factors influencing the morbidity and mortality associated with viremic hepatitis C virus (HCV) infection change over time and place, making it difficult to compare reported estimates. Models were developed for 17 countries (Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong…
- ABDULLAH ÜLKÜ
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection 2018
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
No abstract yet.
- MUSTAFA KEMAL ÇELEN
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection 2018
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
No abstract yet.
- MUSTAFA KEMAL ÇELEN
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene 2003
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.8%
No abstract yet.
- DEVRİM GÖZÜAÇIK

Academicians

287 academicians